BackgroundCheck.run
Search For

Tim P Heffron, 46Burlingame, CA

Known as:
Timothy P Heffron Timothy Paul Heffron Peter P Heffron
Related to:
Megan R Heffron 30

Tim Heffron Phones & Addresses

Burlingame, CA   

Norfolk, NE   

San Francisco, CA   

Ardsley, NY   

291 Beacon St, Boston, MA 02116    617-3756670   

Peoria, IL   

Grand Rapids, MI   

West Hollywood, CA   

New Haven, CT   

San Mateo, CA   

291 Beacon St APT 2, Boston, MA 02116    617-2937904   

Work

Position: Machine Operators, Assemblers, and Inspectors Occupations

Education

Degree: Associate degree or higher
Get Report
Control this profile

Mentions for Tim P Heffron

Tim Heffron resumes & CV records

Resumes

Tim Heffron Photo 18

Tim Heffron

Location:
San Francisco Bay Area
Industry:
Pharmaceuticals
Tim Heffron Photo 19

Tim Heffron

Location:
United States
Tim Heffron Photo 20

Comm Ops At Ge Energy

Position:
Comm Ops at GE Energy
Location:
United States
Industry:
Oil & Energy
Work:
GE Energy
Comm Ops

Publications & IP owners

Us Patents

Phosphoinositide 3-Kinase Inhibitor Compounds And Methods Of Use

US Patent:
7888352, Feb 15, 2011
Filed:
Dec 5, 2007
Appl. No.:
11/951203
Inventors:
Tracy Bayliss - Slough, GB
Irina Chuckowree - Slough, GB
Adrian Folkes - Slough, GB
Sally Oxenford - Slough, GB
Nan Chi Wan - Slough, GB
Georgette Castanedo - Redwood City CA, US
Richard Goldsmith - Belmont CA, US
Janet Gunzner - Berkeley CA, US
Tim Heffron - San Francisco CA, US
Simon Mathieu - Burlingame CA, US
Alan Olivero - Half Moon Bay CA, US
Steven Staben - South San Francisco CA, US
Daniel P. Sutherlin - South San Francisco CA, US
Bing-Yan Zhu - Palo Alto CA, US
Assignee:
Piramed Limited - Slough
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 31/535
C07D 413/14
US Classification:
5142345, 544116
Abstract:
Compounds of Formulas Ia-d where X is S or O, mor is a morpholine group, and Ris a monocyclic heteroaryl group, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for modulating the activity of lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia-d for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Benzopyran And Benzoxepin Pi3K Inhibitor Compounds And Methods Of Use

US Patent:
7928248, Apr 19, 2011
Filed:
Mar 30, 2009
Appl. No.:
12/414403
Inventors:
Steven Do - South San Francisco CA, US
Richard Goldsmith - South San Francisco CA, US
Tim Heffron - South San Francisco CA, US
Aleksandr Kolesnikov - South San Francisco CA, US
Steven Staben - South San Francisco CA, US
Alan G. Olivero - South San Francisco CA, US
Michael Siu - South San Francisco CA, US
Daniel P. Sutherlin - South San Francisco CA, US
Bing-Yan Zhu - South San Francisco CA, US
Paul Goldsmith - Basel, CH
Tracy Bayliss - Basel, CH
Adrian Folkes - Basel, CH
Neil Pegg - Basel, CH
Assignee:
Genentech, Inc. - San Francisco CA
Hoffman-La Roche Inc. - Nutley NJ
International Classification:
C07D 333/00
US Classification:
549 43
Abstract:
Benzopyran and benzoxepin compounds of Formulas I and II, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formulas I and II for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Phosphoinositide 3-Kinase Inhibitor Compounds And Methods Of Use

US Patent:
8383620, Feb 26, 2013
Filed:
Dec 23, 2010
Appl. No.:
12/978106
Inventors:
Tracy Bayliss - Basel, CH
Irina Chuckowree - Basel, CH
Adrian Folkes - Basel, CH
Sally Oxenford - Basel, CH
Nan Chi Wan - Basel, CH
Georgette Castanedo - South San Francisco CA, US
Richard Goldsmith - South San Francisco CA, US
Janet Gunzner - South San Francisco CA, US
Tim Heffron - South San Francisco CA, US
Simon Mathieu - South San Francisco CA, US
Alan Olivero - South San Francisco CA, US
Steven Staben - South San Francisco CA, US
Daniel P. Sutherlin - South San Francisco CA, US
Bing-Yan Zhu - South San Francisco CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 31/535
US Classification:
5142345
Abstract:
Compounds of Formulas Ia-d where X is S or O, mor is a morpholine group, and Ris a monocyclic heteroaryl group, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for modulating the activity of lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia-d for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

4,5-Dihydro-6-Oxa-3-Thia-1-Aza-Benzo[E]Azulene Compounds

US Patent:
8399690, Mar 19, 2013
Filed:
Jan 31, 2011
Appl. No.:
13/018068
Inventors:
Steven Do - South San Francisco CA, US
Richard Goldsmith - South San Francisco CA, US
Tim Heffron - South San Francisco CA, US
Aleksandr Kolesnikov - South San Francisco CA, US
Steven Staben - South San Francisco CA, US
Alan G. Olivero - South San Francisco CA, US
Michael Siu - South San Francisco CA, US
Daniel P. Sutherlin - South San Francisco CA, US
Bing-Yan Zhu - South San Francisco CA, US
Paul Goldsmith - Basel, CH
Tracy Bayliss - Basel, CH
Adrian Folkes - Basel, CH
Neil Pegg - Basel, CH
Assignee:
Genentech, Inc. - South San Francisco CA
F. Hoffman-La Roche Inc. - Nutley NJ
International Classification:
C07D 313/00
C07D 333/00
US Classification:
549354, 549 43
Abstract:
Benzopyran and benzoxepin compounds of Formulas I and II, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formulas I and II for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Phosphoinositide 3-Kinase Inhibitor Compounds And Methods Of Use

US Patent:
8450315, May 28, 2013
Filed:
Oct 29, 2010
Appl. No.:
12/916125
Inventors:
Georgette Castanedo - South San Francisco CA, US
Richard Goldsmith - South San Francisco CA, US
Janet Gunzner - South San Francisco CA, US
Tim Heffron - South San Francisco CA, US
Kimberly Malesky - South San Francisco CA, US
Simon Mathieu - South San Francisco CA, US
Alan Olivero - South San Francisco CA, US
Daniel P. Sutherlin - South San Francisco CA, US
Vickie Tsui - South San Francisco CA, US
Shumei Wang - South San Francisco CA, US
Christian Wiesmann - South San Francisco CA, US
Bing-Yan Zhu - South San Francisco CA, US
Jennafer Dotson - South San Francisco CA, US
Adrian Folkes - Basel, CH
Stephen Shuttleworth - Basel, CH
Sally Oxenford - Basel, CH
Tim Hancox - Basel, CH
Tracy Bayliss - Basel, CH
Assignee:
Genentech, Inc. - South San Francisco CA
F. Hoffmann-La Roche AG - Basel
International Classification:
A61K 31/5377
US Classification:
5142345
Abstract:
Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Phosphoinositide 3-Kinase Inhibitor Compounds And Methods Of Use

US Patent:
2008003, Feb 14, 2008
Filed:
Apr 24, 2007
Appl. No.:
11/789427
Inventors:
Adrian Folkes - Slough, GB
Stephen Shuttleworth - Slough, GB
Sally Oxenford - Slough, GB
Tim Hancox - Slough, GB
Tracy Bayliss - Slough, GB
Georgette Castanedo - Redwood City CA, US
Richard Goldsmith - Belmont CA, US
Janet Gunzner - Berkeley CA, US
Tim Heffron - San Francisco CA, US
Kimberly Malesky - San Francisco CA, US
Simon Mathieu - Burlingame CA, US
Alan Olivero - Half Moon Bay CA, US
Daniel Sutherlin - South San Fransico CA, US
Vickie Tsui - San Francisco CA, US
Shumei Wang - Foster City CA, US
Christian Wiesmann - Brisbane CA, US
Bing-Yan Zhu - Palo Alto CA, US
Jennafer Dotson - Belmont CA, US
Assignee:
Plramed Limited - Slough
Genentech, Inc. - South San Fransico CA
International Classification:
C07D 413/14
A61K 31/5377
A61P 17/00
A61P 25/00
A61P 3/00
A61P 3/10
C12N 9/99
A61P 31/00
A61P 35/00
A61P 41/00
A61P 9/00
US Classification:
514234200, 435184000, 514233800, 514234500, 544122000
Abstract:
Compounds of Formulas Ia and Ib, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Pharmaceutical Compounds

US Patent:
2008007, Mar 27, 2008
Filed:
Apr 24, 2007
Appl. No.:
11/789468
Inventors:
Adrian Folkes - Slough, GB
Stephen Shuttleworth - Slough, GB
Irina Chuckowree - Slough, GB
Sally Oxenford - Slough, GB
Nan Chi Wan - Slough, GB
Georgette Castanedo - Redwood City CA, US
Richard Goldsmith - Belmont CA, US
Janet Gunzner - Berkeley CA, US
Tim Heffron - San Francisco CA, US
Simon Mathieu - Burlingame CA, US
Alan Olivero - Half Moon Bay CA, US
Daniel Sutherlin - South San Francisco CA, US
Bing-Yan Zhu - Palo Alto CA, US
Assignee:
Piramed Limited - Slough
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 31/5377
A61K 31/551
A61P 25/00
A61P 29/00
A61P 3/00
A61P 31/00
A61P 35/00
A61P 37/00
A61P 9/00
C07D 491/048
C07D 495/04
US Classification:
514218000, 514232500, 514234200, 540575000, 544117000
Abstract:
Compounds of Formulae Ia and Ib, and stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Phosphoinositide 3-Kinase Inhibitor Compounds And Methods Of Use

US Patent:
2008026, Oct 30, 2008
Filed:
Dec 5, 2007
Appl. No.:
11/951189
Inventors:
Georgette Castanedo - Redwood City CA, US
Jennafer Dotson - Belmont CA, US
Richard Goldsmith - Belmont CA, US
Janet Gunzner - Berkeley CA, US
Tim Heffron - San Francisco CA, US
Simon Mathieu - Burlingame CA, US
Alan Olivero - Half Moon Bay CA, US
Daniel P. Sutherlin - South San Fransico CA, US
Shumei Wang - Foster City CA, US
Bing-Yan Zhu - Palo Alto CA, US
Steven Staben - South San Fransico CA, US
Vickie Tsui - Burlingame CA, US
Tracy Bayliss - Slough, GB
Irina Chuckowree - Slough, GB
Adrian Folkes - Slough, GB
Nan Chi Wan - Slough, GB
International Classification:
A61K 31/5377
C07D 495/04
C07D 413/14
A61P 35/00
A61K 31/519
US Classification:
5142342, 544278, 544117, 5142601
Abstract:
Compounds of Formulas Ia-d where X is S or O, mor is a morpholine group, and Ris a monocyclic heteroaryl group, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for modulating the activity of lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia-d for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Possible Relatives

David G Heffron  Dorothy E Heffron  Douglas V Heffron  Elizabeth A Heffron  Florence R Heffron  Howard T Heffron  Jessica L Heffron  Tim C Johnson  Tim R White  Tim P Jolly 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.